Rasna Therapeutics Stock Annual Yield
RASP Stock | USD 0 0.00 0.00% |
Rasna Therapeutics fundamentals help investors to digest information that contributes to Rasna Therapeutics' financial success or failures. It also enables traders to predict the movement of Rasna Pink Sheet. The fundamental analysis module provides a way to measure Rasna Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rasna Therapeutics pink sheet.
Rasna |
Rasna Therapeutics Company Annual Yield Analysis
Rasna Therapeutics' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Rasna Therapeutics has an Annual Yield of 0.0%. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Annual Yield (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
Rasna Fundamentals
Return On Equity | -2.94 | |||
Return On Asset | -3.7 | |||
Current Valuation | 1.22 M | |||
Shares Outstanding | 771.81 M | |||
Shares Owned By Insiders | 85.10 % | |||
Price To Book | 0.31 X | |||
EBITDA | 254.41 K | |||
Net Income | (686.59 K) | |||
Cash And Equivalents | 10.52 K | |||
Total Debt | 91.97 K | |||
Debt To Equity | 0.20 % | |||
Current Ratio | 0.04 X | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (312.66 K) | |||
Number Of Employees | 13 | |||
Beta | -57.77 | |||
Market Capitalization | 12.04 M | |||
Total Asset | 85.28 K | |||
Z Score | 84.6 | |||
Net Asset | 85.28 K |
About Rasna Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rasna Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rasna Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rasna Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Rasna Pink Sheet Analysis
When running Rasna Therapeutics' price analysis, check to measure Rasna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rasna Therapeutics is operating at the current time. Most of Rasna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rasna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rasna Therapeutics' price. Additionally, you may evaluate how the addition of Rasna Therapeutics to your portfolios can decrease your overall portfolio volatility.